Pricing Log in Create free account

Clene Inc. (CLNN) vs Heron Therapeutics, Inc. (HRTX)

Clene Inc. and Heron Therapeutics, Inc. are both Biotechnology companies. Heron Therapeutics, Inc. is the larger, with a market value of $70.4M against $63.1M — 1.1× the size. Clene Inc. grew revenue faster over the last twelve months: 11.2% against −4.44%. Heron Therapeutics, Inc. has the higher net margin (−14.6% vs −11,271.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Heron Therapeutics, Inc. leads on 12 and Clene Inc. on 4.

Valuation

Metric CLNN HRTX Biotechnology median
P/E n/m n/m 10.85
P/S 239.62 0.48 9.49
P/B n/m 12.06 2.18
Price to free cash flow n/m n/m 25.85
EV/EBITDA n/m n/m 0.70
EV/Sales 224.37 1.28 8.99
Earnings yield (53.92%) (32.43%) (31.76%)
Free cash flow yield (29.15%) (20.12%) (21.84%)

Profitability

Metric CLNN HRTX Biotechnology median
Gross margin 68.49% 71.47% 68.51%
Operating margin (8,928.57%) (5.69%) 0.00%
Net margin (11,271.43%) (14.55%) 0.00%
Free cash flow margin (6,984.45%) (9.26%) 0.00%
Return on equity 197.50% 0.00% (50.82%)
Return on assets (120.65%) (8.99%) (46.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLNN HRTX Biotechnology median
Revenue growth (TTM) 11.21% (4.44%) 6.96%
EPS growth (last fiscal year) 53.26% (33.33%) 29.88%
Revenue growth, 5-year CAGR (0.59%) 11.81% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLNN HRTX Biotechnology median
Debt to equity (0.42) 0.00 0.00
Current ratio 0.85 2.33 4.84
Net debt to EBITDA (0.39) (643.88) 1.01

Dividend

Metric CLNN HRTX Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric CLNN HRTX Biotechnology median
Market cap 63.07m 70.36m 163.56m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack